Lithium: Clinical Considerations in Internal Medicine - 20/08/11
, Scott A. Freeman, MD b
Requests for reprints should be addressed to Marlene P. Freeman, MD, Women’s Mental Health Program, Departments of Psychiatry, Obstetrics and Gynecology, and Nutritional Sciences; University of Arizona College of Medicine, 1501 N. Campbell Avenue, 7th Floor, Tucson, AZ 85724-5002.Abstract |
Bipolar Disorders affect up to 5% of the population. While the pharmacological options for the treatment of bipolar disorder have expanded over the past several years, lithium remains an inexpensive and efficacious treatment for bipolar disorder. Lithium has been demonstrated to be an effective treatment for acute mania, bipolar depression, the prophylactic treatment of bipolar disorder, and as an augmentation agent in the treatment of unipolar major depression. Lithium also is the only mood stabilizer that has been demonstrated to lower the suicide rate in patients with bipolar disorder. Use in special populations, side effects and toxicity, and drug interactions are discussed. Important laboratory monitoring guidelines are included in this review. Lithium remains an important intervention for the treatment of mood disorders.
El texto completo de este artículo está disponible en PDF.Keywords : Lithium, Bipolar disorder, Mania, Depression, Mood stabilizer
Esquema
Vol 119 - N° 6
P. 478-481 - juin 2006 Regresar al número
Artículo precedente
- The Ever-Expanding Association Between Rheumatologic Diseases and Tuberculosis
- Carlos Franco-Paredes, Alejandro Díaz-Borjon, Mark A. Senger, Lorena Barragan, Michael Leonard
- Back to Basics
- David Rubin, Barbara McGovern, Richard I. Kopelman
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?